Literature DB >> 19025735

Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.

Timothy A Hill1, Scott G Stewart, Christopher P Gordon, Stephen P Ackland, Jayne Gilbert, Benjamin Sauer, Jennette A Sakoff, Adam McCluskey.   

Abstract

Cantharidin (1) and its derivatives are of significant interest as serine/threonine protein phosphatase 1 and 2A inhibitors. Additionally, compounds of this type have displayed growth inhibition of various tumour cell lines. To further explore both of these inhibition pathways, a number of amide-acid norcantharidin analogues (15-26) were prepared. Compounds 23 and 24, containing two carboxylic acid residues, showed good PP1 and PP2A activity, with IC(50) values of approximately 15 and approximately 3 mum, respectively. Substituted aromatic amide analogues 45, 48, 49, 52, 53, and 54 also displayed good PP1 and PP2A inhibition, with IC(50) values in the range of 15-10 microM (PP1) and 11-5 microM (PP2A). However, bulky ortho substituents on the aromatic ring caused the aromatic ring to be skewed from the NCO planarity, leading to a decrease in PP1 and PP2A inhibition. A number of analogues, 20, 22, 25 and 46, showed excellent tumour growth inhibition, with 46 in particular being more potent than the lead, norcantharidin 2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19025735     DOI: 10.1002/cmdc.200800192

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  13 in total

Review 1.  Norcantharidin, a protective therapeutic agent in renal tubulointerstitial fibrosis.

Authors:  Ying Li; Yan Ge; Fu You Liu; You Ming Peng; Lin Sun; Jun Li; Qiong Chen; Yan Sun; Kun Ye
Journal:  Mol Cell Biochem       Date:  2011-09-29       Impact factor: 3.396

2.  Synthesis of a norcantharidin-tethered guanosine: Protein phosphatase-1 inhibitors that change alternative splicing.

Authors:  Stefan Kwiatkowski; Vitaliy M Sviripa; Zhaiyi Zhang; Alison E Wendlandt; Claudia Höbartner; David S Watt; Stefan Stamm
Journal:  Bioorg Med Chem Lett       Date:  2015-12-18       Impact factor: 2.823

Review 3.  Targeting protein serine/threonine phosphatases for drug development.

Authors:  Jamie L McConnell; Brian E Wadzinski
Journal:  Mol Pharmacol       Date:  2009-03-19       Impact factor: 4.436

4.  Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling.

Authors:  Flora Cimmino; Maria Nunzia Scoppettuolo; Marianeve Carotenuto; Pasqualino De Antonellis; Valeria Di Dato; Gennaro De Vita; Massimo Zollo
Journal:  J Neurooncol       Date:  2011-07-07       Impact factor: 4.130

5.  Norcantharidin inhibits renal interstitial fibrosis by downregulating PP2Ac expression.

Authors:  Tao Hou; Zheng Xiao; Ying Li; Yan-Hua You; Hua Li; Yu-Ping Liu; Yi-Yun Xi; Jun Li; Shao-Bin Duan; Hong Liu; Lin Sun; You-Ming Peng; Fu-You Liu
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

6.  Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C.

Authors:  Debasish Chattopadhyay; Mark R Swingle; Edward A Salter; Eric Wood; Brandon D'Arcy; Catherine Zivanov; Kevin Abney; Alla Musiyenko; Scott F Rusin; Arminja Kettenbach; Larry Yet; Chad E Schroeder; Jennifer E Golden; Wade H Dunham; Anne-Claude Gingras; Surajit Banerjee; David Forbes; Andrzej Wierzbicki; Richard E Honkanen
Journal:  Biochem Pharmacol       Date:  2016-03-23       Impact factor: 5.858

7.  4-(3,5-Dioxo-10-oxa-4-aza-tricyclo-[5.2.1.0]decan-4-yl)-10-oxa-4-aza-tricyclo-[5.2.1.0]decane-3,5-dione.

Authors:  Peng-Peng Wang; Qiu-Yue Lin; Fan Zhang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-01-14

8.  Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-kB activity.

Authors:  Chao-Bin Yeh; Ming-Ju Hsieh; Yi-Hsien Hsieh; Ming-Hsien Chien; Hui-Ling Chiou; Shun-Fa Yang
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

9.  Insights into the key interactions between human protein phosphatase 5 and cantharidin using molecular dynamics and site-directed mutagenesis bioassays.

Authors:  Ji-Yuan Liu; Xi-En Chen; Ya-Lin Zhang
Journal:  Sci Rep       Date:  2015-07-20       Impact factor: 4.379

10.  Cantharidin and its anhydride-modified derivatives: relation of structure to insecticidal activity.

Authors:  Wenbo Sun; Zhongyi Liu; Yalin Zhang
Journal:  Int J Mol Sci       Date:  2012-12-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.